Phenotypic and Functional Characterization of CAR-T Cells
The successful use of immunotherapies to help combat cancer has expanded rapidly in the last few years, with many therapies now approved for clinical use. The precision of the immune system allows a more targeted approach to killing cancer cells, while sparing healthy cells, when compared to traditional chemotherapeutic strategies. One key area of advance has been in the use of gene-modified cell therapies with the introduction of chimeric antigen receptor (CAR) T cells leading the field.
Download this whitepaper to learn more about the benefits of this approach such as discover a solution that can:
- Reduced cost of manufacturing
- Improved long-term storage of cells
- Increased consistency of larger batches
